What is Spravato?
David Connell
November 5, 2023
The insurance-backed nasal spray is a promising treatment for individuals suffering from treatment-resistant depression or major depressive disorder with suicidal ideation.
Your individual experience may vary based on your medical history, genetics, environment, habits, and other factors.
Highly effective for treating TRD and MDSI
Only needs to be administered
1 or 2 times per week
Backed by most insurance
Johnson & Johnson REMS certification supports a safe procedure
Does not cause weight gain like other antidepressants
Needs to be done at a treatment facility
Unable to drive after treatment
Requires 4-6 doses
No generic option
Need to meet the requirements of
trying 2 antidepressants
In a study conducted by Aspire, esketamine was found to decrease the MADRS total score by 4 points on the 18-point scale within a 24-hour period after initial treatment.
In a study conducted by Aspire, esketamine was found to decrease the MADRS total score by an average of 4 points on the 18-point scale within a 24-hour period of the first treatment.
Getting mental health care has never been easier. Wondering if Spravato is right for you?Â
Matching individuals with innovative treatments, products & service providers.Â
Matching individuals with innovative treatments, products & service providers.Â
© Copyright 2024 Psycle Health, Inc.  All rights reserved.
ENTER YOUR EMAIL BELOW TO GET INSIDER UPDATES DELIVERED STRAIGHT TO YOUR INBOX.😌ðŸ§